- Home
- SRZN vs TURN Comparison
SRZN vs TURN Comparison
Compare SRZN & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- TURN
- Stock Information
- Founded
- SRZN 2015
- TURN 1981
- Country
- SRZN United States
- TURN United States
- Employees
- SRZN N/A
- TURN N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- TURN Finance/Investors Services
- Sector
- SRZN Health Care
- TURN Finance
- Exchange
- SRZN Nasdaq
- TURN Nasdaq
- Market Cap
- SRZN 38.1M
- TURN 32.3M
- IPO Year
- SRZN N/A
- TURN N/A
- Fundamental
- Price
- SRZN $9.10
- TURN $3.33
- Analyst Decision
- SRZN
- TURN
- Analyst Count
- SRZN 0
- TURN 0
- Target Price
- SRZN N/A
- TURN N/A
- AVG Volume (30 Days)
- SRZN 30.0K
- TURN 17.2K
- Earning Date
- SRZN 11-06-2024
- TURN 11-26-2024
- Dividend Yield
- SRZN N/A
- TURN N/A
- EPS Growth
- SRZN N/A
- TURN N/A
- EPS
- SRZN N/A
- TURN N/A
- Revenue
- SRZN $10,000,000.00
- TURN $129,297.00
- Revenue This Year
- SRZN N/A
- TURN N/A
- Revenue Next Year
- SRZN N/A
- TURN N/A
- P/E Ratio
- SRZN N/A
- TURN N/A
- Revenue Growth
- SRZN N/A
- TURN 6.32
- 52 Week Low
- SRZN $5.55
- TURN $3.12
- 52 Week High
- SRZN $16.19
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- SRZN 40.89
- TURN 56.49
- Support Level
- SRZN $8.90
- TURN $3.23
- Resistance Level
- SRZN $14.18
- TURN $3.36
- Average True Range (ATR)
- SRZN 1.28
- TURN 0.09
- MACD
- SRZN -0.26
- TURN 0.01
- Stochastic Oscillator
- SRZN 3.87
- TURN 100.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.